Related Experiment Videos
Transgenic rabbit models for biomedical research: current status, basic methods and future perspectives
1Department of Pathology, Institute of Basic Medical Sciences, University of Tsukuba, Japan. j-fan@md.tsukuba.ac.jp
Pathology International
|October 3, 1999
Summary
Genetically modified rabbits, created using recombinant DNA technology, serve as valuable models for human diseases and efficient producers of therapeutic proteins, advancing biomedical research and biotechnology.
Area of Science:
- Biotechnology and Genetic Engineering
- Animal Models in Research
- Molecular Biology
Background:
- Recombinant DNA technology has enabled the creation of genetically modified animals.
- Transgenic rabbits have emerged as significant models over the past decade.
- Advancements in gene targeting and cloning facilitate transgenic rabbit production.
Purpose of the Study:
- To review progress in the development of transgenic rabbits.
- To highlight applications of transgenic rabbits as human disease models.
- To discuss their use in producing therapeutic proteins.
Main Methods:
- Review of scientific literature on transgenic rabbit technology.
- Analysis of gene targeting and animal cloning techniques.
- Evaluation of applications in disease modeling and bioproduction.
Main Results:
- Transgenic rabbits offer a large mammal model for studying human diseases.
- They provide a viable system for bioproduction of foreign proteins.
- Progress in gene targeting and cloning enhances their utility.
Conclusions:
- Transgenic rabbits are crucial tools in biomedical research.
- They hold significant potential for therapeutic protein production.
- Continued advancements will expand their applications in science and industry.